Prevention and control of HPV and HPV related cancers in Ireland and the UK: lessons learnt and the way forward

Meeting objectives:

• Give an overview of the health care systems in both countries.
• Provide a summary of the epidemiology, burden of disease and surveillance related to HPV and HPV related cancers in Ireland and the UK.
• Discuss successes, topical issues and challenges related to HPV vaccination and screening particular to Ireland and the different regions in UK.
• Gain insight in the various stakeholder perspectives.
• Propose recommendations for the way forward.

Background document (pdf, 1.7 MB)

November 30, 2017

SESSION 1: OPENING AND OBJECTIVES
Chairs: Liudmila Mosina and Brenda Corcoran

• Welcome (pdf, 313 kB) by Simon Harris, MOH Ireland
  
  
• Welcome and presentation of the objectives by HPV Prevention and Control Board     (pdf, 788 kB, )
  Alex Vorsters, University of Antwerp, HPV Prevention and Control Board (Belgium)

 SESSION 2: THE HEALTH CARE SYSTEMS IN IRELAND AND THE UK

Chairs: Liudmila Mosina & Brenda Corcoran

• The Health Care System in the UK (pdf, 2 MB)
  Vanessa Saliba, Public Health England (UK)
  
  
• Health Care System in Ireland (pdf, 501 kB)
  Kevin Kelleher, Health Service Executive (Ireland)

SESSION 3: EPIDEMIOLOGY, BURDEN OF DISEASE AND SURVEILLANCE OF HPV AND HPV RELATED CANCERS IN IRELAND AND THE UK
Chairs: Mario Poljak & Scott Wittet

• HPV associated cancers in Ireland (pdf, 891 kB)
  Mairead O’Connor, National Cancer Registry Ireland
  
  
• Surveillance of HPV; a focus on the UK
  Kate Cuschieri, Royal Infirmary of Edinburgh  (UK)
  
  
• Northern Ireland (pdf, 496 kB)
  Lesley Anderson, Queen’s University Belfast (UK)

SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK
Chairs: Mario Poljak and Scott Wittet

• HPV vaccination programme in the UK (pdf, 1.3 MB)
  Vanessa Saliba, Public Health England (UK)
  
  
• HPV vaccination programme in Ireland (pdf, 3.2 MB)
  Brenda Corcoran, Health Service Executive (Ireland)

SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK (Cont'd)
Chairs: Susanne Krûger-Kjaer and Susan Wang

• HPV vaccination in  Northern Ireland: Spill-over of anti-vaccine group messagesfrom Ireland (pdf, 276 kB)
  Lucy Jessop, Public Health Agency (UK)
  
  
• The link between communication and coverage, the case of Ireland (pdf, 2 MB)
  Paul Connors, Health Service Executive (Ireland)
  
  
• Communication and the HPV vaccine. What do parents and teenagers in England think?
  Louise Letley, Public Health England (UK)
  
  
• Panel debate : impact of communication on coverage and vice versa
  Moderator: Robert O’Connor
  Panel: Susan Mitchel, Paul Connors, Grainne O’Rourke, Catherine Fegan, David Robert Grimes

 SESSION 5: HPV AND HPV RELATED CANCER SCREENING PROGRAMMES IN IRELAND AND THE UK
Chairs: Margaret Stanley & Eduardo Franco

• HPV screening programme and implementation in Ireland (pdf, 3.1 MB)
  Grainne Flannelly/John Gleeson, Cervical Check (Ireland)
  
  
• HPV screening programme and implementation in England and Wales (pdf, 377 kB)
  Ruth Stubbs, Public Health England (UK)
  
  
• Self-sampling studies from Scotland (pdf, 3 MB)
  Grzayna Stanczuk, Western Isles Hospital (UK)
  
  
• HPV based screening implementation in Scotland and impact of immunisation
  Tim Palmer, University of Edinburgh (UK)

SESSION 6: KEY NOTE 
Chairs: Rob O'Connor & Bruce Gellin

• The human papilloma virus vaccine; from bench to bedside (pdf, 1.5 MB)
  Doug Lowy, National Cancer Institute (US)

December 1, 2017

SESSION 7: CHALLENGES AND OPPORTUNITIES IN HPV CONTROL
Chairs: Margaret Stanley and Paolo Bonanni

• The HPV crisis in Ireland: a survey among health care provider (pdf, 794 kB)
  Poster: 'The HPV vaccine crisis' (pdf, 794 kB)
  Donal Brennan, Mater Misericordiae University Hospital (Ireland)
  
  
• Panel debate on HPV vaccination programmes and the role of health care providers
  Moderator: Pierre Van Damme
  Donal Brennan, Paolo Bonanni, Ros Quinlan
  
  
• New developments in anal screening and implications of vaccine in MSM
  Richard Gilson, University College London (UK)
  
  
• Gender neutral vaccination. The discussion in the UK and globally (pdf, 1.2 MB)
  Mark Jit, London School for Hygiene and Tropical Medicine (UK)

SESSION 8: THE PATIENT'S PERSPECTIVE
Chairs: Mira Kojouharova & Sharon Hanley

• Cervical cancer victim to testify (pdf, 876 kB)
  Stefanie Veraghtert, The Big C (Belgium)

SESSION 9: THE WAY FORWARD: BREAK- OUT SESSIONS
Chairs: Alex Vorsters and Kate Cuschieri

• Break-out sessions:

What are important issues to take into account when considering gender neutral vaccination? (pdf, 179 kB)
Chair: Peter Baker

What should be the research topics to anticipate on future challenges and maintain good coverage? (pdf, 180 kB)
Chair: Doug Lowy

Lessons learnt from Ireland how to mitigate a crisis. (pdf, 182 kB)
Chair: Liudmila Mosina

How to articulate and convey “success” of the vaccine program to support future engagement (and to overcome spurious claims)? (pdf, 179 kB)
Chair: Mark Kane

• Presentations from the break-out sessions & discussion

 SESSION 10: MEETING CONCLUSIONS
Chairs: Pierre Van Damme and Mark Kane

• Presentation of the meeting conclusions  (pdf, 488 kB) & feedback
  Rob O’Connor & and Brenda Corcoran